New antithrombotic agents
- 1 April 1999
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 353 (9162) , 1431-1436
- https://doi.org/10.1016/s0140-6736(98)09233-2
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.Journal of Clinical Investigation, 1997
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Importance of factor Xa in determining the procoagulant activity of whole-blood clots.Journal of Clinical Investigation, 1993
- Molecular and Cellular Biology of Blood CoagulationNew England Journal of Medicine, 1992
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991
- HeparinNew England Journal of Medicine, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKEThe Lancet, 1989